Eli Lilly and : Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance® (empagliflozin) on risk of heart failure hospitalization and death in adults following a heart attack -April 06, 2024 at 09:54 am EDT
Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance® on risk of heart failure hospitalization and death in adults following a...